Global Plasma Leaders Collaborate to Accelerate Development of Potential...
OSAKA, Japan & KING OF PRUSSIA, Pa. Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited...
View ArticleEuropean Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of...
View ArticleCORRECTING and REPLACING Global Plasma Leaders Collaborate to Accelerate...
OSAKA, Japan & KING OF PRUSSIA, Pa. Please replace the release with the following corrected version due to multiple revisions to the Octapharma boilerplate and inclusion of additional...
View Article訂正・差し替え グローバルで血漿分画製剤領域をリードする企業による 新型コロナウイルス感染症(COVID-19)に対する...
大阪 & 米国ペンシルベニア州キング・オブ・プルシア (ビジネスワイヤ)– CSL...
View ArticleCullgen Announces Publication of Small Molecule BRAF Protein Degraders in...
SAN DIEGO Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced...
View ArticleSt. Luke’s University Health Network One of the First in the World to Pilot...
IRVINE, Calif. & BETHLEHEM, Pa. Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to...
View ArticleGenetron Health Announces Its Novel Coronavirus Nucleic Acid Detection Kit Is...
BEIJING Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announces that its independently developed Detection Kit for Novel...
View ArticleMorinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS...
View Article森永乳业用于婴儿配方奶的益生菌长双歧杆菌BB536获得FDA GRAS认证
东京 (美国商业资讯)–日本领先的乳制品公司森永乳业株式会社(Morinaga Milk Industry Co., Ltd., TOKYO:2264)今天宣布,其专利益生菌森永长双歧杆菌BB536已获得用于足月儿配方奶的FDA GRAS(公认安全)认证。...
View Article森永乳業:「ビフィズス菌BB536」が乳児向けGRASを取得
東京 (ビジネスワイヤ) — 森永乳業では「ビフィズス菌BB536(Bifidobacterium longum BB536)」において、これまでに一般食品を対象としたGRAS(※2)を取得しております。育児用ミルク等の乳児向けの食品に対しては、専門家の厳格な審査により自己認証GRAS(infant...
View Article全球血浆领导者携手加快开发有望治疗COVID-19的超免疫产品
日本大阪和宾夕法尼亚州普鲁士王市 (美国商业资讯)–Biotest、BPL、LFB和Octapharma已加入CSL Behring (ASX:CSL/USOTC:CSLLY)和武田药品工业株式会社(Takeda Pharmaceutical Company Limited,...
View ArticleLFB宣布FDA核准新的重组VIIa凝血因子SEVENFACT®,用于治疗伴抑制因子的成人和青少年血友病A或B患者
法国于利斯 –(美国商业资讯)–LFB今天宣布,美国食品药品管理局(FDA)已核准SEVENFACT®的生物制剂许可申请(BLA) 2061,SEVENFACT®是一种新型重组VIIa凝血因子[(重组)VIIa凝血因子-jncw],用于治疗和控制伴有抑制因子(中和抗体)的成人和12岁及以上青少年血友病A或B患者发生的出血发作。LFB和US WorldMeds的合资企业HEMA...
View ArticleLFB、新しい組み換え型血液凝固第VIIa因子をインヒビター保有血友病A/Bの成人/青年患者の治療薬としてSEVENFACT®をFDAが承認と発表
仏レジュリス — (ビジネスワイヤ) —...
View Articleセントルーク大学ヘルスネットワークが遠隔患者管理ソリューションMasimo...
米カリフォルニア州アーバイン & ペンシルベニア州ベスレヘム (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、セントルーク大学ヘルスネットワーク(SLUHN)がCOVID-19感染患者の急増に対応するための革新的なソリューションを求めている中、同ネットワークがマシモ・セーフティーネット(Masimo...
View ArticlePharmaCyte Biotech Enters into License Agreement for COVID-19 Diagnostic Kits
LAGUNA HILLS, Calif. PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation...
View ArticleNeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab)...
SYDNEY NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced successful completion...
View ArticleHPC-AI Advisory Council and National Supercomputing Centre Singapore Expand...
SINGAPORE The HPC-AI Advisory Council (HPCAIAC) and the National Supercomputing Centre (NSCC) Singapore announced today that they have joined the global fight against COVID-19 by expanding the 2020...
View Article欧盟委员会核准武田ALUNBRIG® (brigatinib)用于ALK+ NSCLC一线治疗
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited) (TSE:4502/NYSE:TAK)今天宣布,欧盟委员会(EC)扩大了ALUNBRIG...
View ArticleCarbios在著名的科学杂志《自然》上发表了一篇 关于酶循环技术的文章
法国克莱蒙特·费朗 CARBIOS 公司(巴黎泛欧交易所代码: ALCRB)宣布在著名的科学杂志《自然》上发表一篇文章,题为“一种用于分解和回收利用塑料瓶的工程化聚酯解聚酶”。该文章是由Carbios的科学家和该公司著名的学术合作伙伴图卢兹生物技术研究所1共同撰写。...
View ArticleSt. Luke’s University Health Network是世界首批试用远程患者管理解决方案Masimo...
加州尔湾和宾夕法尼亚州伯利恒 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,St. Luke’s University Health Network (SLUHN)是全球首批使用Masimo SafetyNet™监测住院患者的机构之一,SLUHN正在寻求创新解决方案来治疗激增的COVID-19感染患者。Masimo...
View Article